SAFE AND EFFECTIVE METHOD OF TREATING ULCERATIVE COLITIS WITH ANTI-IL12 / IL23 ANTIBODY
CY1126163T1Undetermined Publication Date: 2026-07-31JANSSEN BIOTECH INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100402T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-09-04
- Filing Date
- 2023-08-09
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2043-08-09
Abstract
Methods and compositions are described for clinically proven safe and effective treatment of ulcerative colitis, particularly moderate to severe active ulcerative colitis in patients who have had an inadequate response to or are intolerant to a conventional or existing therapy by intravenous and / or subcutaneous administration of an avu-IL-12 / IL-23p40 antibody.
Need to check novelty before this filing date? Find Prior Art